Inhibitory effects of rupatadine on mast cell histamine release and skin wheal development induced by Ascaris suum in hypersensitive dogs

Drug Development Research

Volumn 44, Issue 2-3, 1998, Pages 49-55

  Queralt, Mireia ^a   Brazís, Pilar ^a   Merlos, Manuel ^b   Puigdemont, Anna ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Grupo Uriach   (Spain)

Author keywords

Ascaris suum antigen; Dog; H1 antihistamines; Rupatadine; Skin mast cells

Indexed keywords

FOROPAFANT; HISTAMINE; LORATADINE; RUPATADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCARIS; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG POTENCY; HISTAMINE RELEASE; HUMAN TISSUE; HYPERSENSITIVITY; IMMUNOMODULATION; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; SKIN INFLAMMATION; URTICARIA;

EID: 0031691907     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199806/07)44:2/3<49::AID-DDR1>3.0.CO;2-A     Document Type: Article

References (26)

1. Amon U, Nitschke M, Dieckmann D, Gibbs BF, Wehrahn C, Wolff HH (1994): Activation and inhibition of mediator release from skin mast cells: A review of in vitro experiments. Clin Exp Allergy 24:1098-1104.
2. Brazís P, Queralt M, DeMora F, Ferrer L, Puigdemont A (1998): Comparative study of mast cell histamine release in atopic, ascaris-hypersensitive and healthy dogs. Vet Immunol Immunopathol (in press).
3. DeMora F, García G, Ferrer L, Arboix M (1993): Canine cutaneous mast cells dispersion and histamine secretory characterization. Vet Immunol Immunopathol 39:421-429.
4. 1-receptor antagonist drugs. Allergy Clin Immunol 98:S307-S318.
5. Fadal R (1993): IgE-mediated hypersensitivity reactions. Otolaryngology-head and neck surgery 109(3):565-578.
6. 1-antihistamines on histamine release from dispersed canine cutaneous mast cells. Am J Vet Res 58:293-297.
7. Halliwell REW Schwartzman RM (1971): Atopic disease in the dog. Vet Rec 89:209-214.
8. Herbert JM, Laplace MC, Bernat A, Salel V, Maffrand JP (1992): Effect of SR-27417A on oedema formation induced in rabbit skin by platelet-activating factor or antigen. Eur J Pharmacol 216:175-181.
9. Jackson HA, Miller HRP, Halliwell REW (1996): Canine leucocyte histamine release: Response to antigen and to anti-IgE. Vet Immunol Immunopathol 53:195-206.
10. Kimura I, Moritani Y, Tanizaki Y (1973): Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 3:195-202.
11. 1-antagonist, desethoxycarbonylloratadine. J Allergy Clin Immunol 93:494-500.
12. 2+ levels and leukotriene release: Novel mechanism of action independent of the anti-histamine activity. Eur J Pharmacol 266:219-227.
13. Merlos M, Balsa D, Cirai M, García-Rafanell J, Forn J (1994): Antiallergic properties of UR-12592, a dual histamine and PAF antagonist. Allergy Clin Immunol News Suppl(2):284.
14. Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J (1997a): Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 280(1): 114-121.
15. Merlos M, Balsa D, Giral M, Ferrando R, García-Rafanell J, Forn, J (1997b): Inhibición de la exocitosis de las células mastocitarias peritoneales de rata por la rupatadina fumarato: estudio con diferentes secretagogos. Methods Find Exp Clin Phannacol 19(Suppl 17):148.
16. 1-antagonist loratadine on histamine release from human basophils. Int Arch Allergy Immunol 105:12-17.
17. Miller WH, Griffin CE, Scott DW, Angarano DK, Norton AL (1989): Clinical trial of DVM Derm Caps in the treatment of allergic disease in dogs: A nonblinded study. J Am Anim Hosp Assoc 25:163-168.
18. Monroe EW, Daly AF, Shalhoub RF (1997): Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines. J Allergy Clin Immunol 99:S798-S806.
19. Nimmo Wilkie JS, Yager JA, Wilkie BN, Pascoe PJ (1992): Changes in cell-mediated immune responses after experimentally-induced anaphylaxis in dogs. Vet Immunol Immunopathol 32:325-338.
20. 1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. Allergy 49:246-253.
21. Queralt M, Merlos M, Giral M, Puigdemont A (1996): Dual effect of a new compound, nipatadine, on edema induced by platalet-activating factor and histamine in dogs: Comparison with antihistamines and PAF antagonists. Drug Dev Res 39:12-18.
22. 1-antagonists. Clin Exp Allergy 20(2):3-17.
23. Shore PA, Burkhalter A, Cohn, VH (1959): A method for the fluorimetric assay of histamine in tissues. J Pharmacol Exp Ther 127: 182-186.
24. Sullivan TJ, Parker KL, Eisen SA, Parker CW (1975): Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J Immunol 114:1480-1485.
25. Thomsen MK (1991): The role of neutrophil-activating mediators in canine health and disease (with special reference to the role of leukotrienes in inflammatory dermatoses). J Vet Pharmaeol Therap 14:113-133.
26. 1-antihistamines during the early and late reactions to antigen. J Allergy Clin Immunol 90:720-725.